May 26, 2023 — Some health insurance plans seem to be panicking. For years, the order of things was simple. People with obesity had only themselves to blame and besides, nothing could be done about their condition. So health insurers routinely denied coverage for medical care of obesity. “Regardless of any potential medical benefit” was the language written into […]
May 25, 2023 — Are we ready for a re-think of obesity and metabolic health? Ready to change the conversation about obesity medicines and bariatric surgery? Sergio Santoro, Scott Shikora, and Ricardo Cohen certainly think so. Writing in Obesity Surgery, they say it’s time to say goodbye to bariatric surgery and move on to the framework of metabolic surgery. […]
May 23, 2023 — A pair of reports on Monday raised the possibility that we may soon have oral obesity meds that match the remarkable effectiveness of injections. One of these drugs is an oral formulation of semaglutide that’s already available at a much lower oral dose for diabetes under the brand name of Rybelsus. Novo Nordisk makes it. […]
May 20, 2023 — ECO2023 closed today with a clear focus on future progress in obesity. Lee Kaplan offered a view of what that future might look like with a focus on access and delivery of chronic care for obesity. Kaplan told us the future of obesity care lies in getting beyond merely saying that obesity is a disease. […]
May 18, 2023 — It is impossible to miss. At ECO2023, we are seeing tremendous excitement about advances in obesity care – mixed with concern about what happens when those advances meet with reality. As ECO2023 unfolds, we’re hearing more about the advances that new obesity medicines are offering, but we’re also hearing reminders about the gap between the […]
May 17, 2023 — The current sensation around advanced medicines for obesity all too often focuses on a single outcome – weight loss. On the opening day of ECO2023, a symposium by the SQOT project reminds us that outcomes other than weight loss can matter to patients quite a lot. In reality, the reason that many people seek obesity […]
May 15, 2023 — We’re headed to Dublin this week for the European Congress on Obesity – ECO2023. At a pace that will surely be overwhelming, we expect to encounter some of the world’s best researchers, clinicians, and patient advocates bringing us new insights. This comes at an exciting time for the field because advanced treatment options are causing […]
May 14, 2023 — “Fix the food first. Let’s see if these drugs are actually better than real food.” Those words from Robert Lustig (the sugar is poison guy) capture the dissonance obesity medicines are causing for people who believe that obesity is simply the result of bad food. They’re framing care for people with obesity as an obstacle […]
May 11, 2023 — The natural killers of our immune system – lymphocytes known as natural killer cells – increasingly seem to have a role in the pathophysiology of obesity and in the response to its treatment. Just this week, researchers from Ireland published a study showing that semaglutide for obesity may restore more normal function of these cells. […]
May 9, 2023 — With all the sensational reporting about semaglutide and tirzepatide for obesity – often with the emphasis on weight loss – you might think a revolution is underway. Yes, it is coming. But the truth is that it hasn’t even started yet. At present, for a number of reasons, we are barely scratching the surface of […]
